Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319d4f373d5eba3b7b92cea4f5e534f9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-25 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-25 |
filingDate |
2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17d7a12c11d32a27741919efba46dfca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa6fb7c22516e0ccf6f4ec587f7198df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dc314ab5a4731912929fb92f022da75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3baadb45a31e9b2b82c9f6a1037ef1d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33a9e9fe0cbe0121f0450ec0a68d9f00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d43951e0452530654ede522f240fbf8 |
publicationDate |
2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2066338-A2 |
titleOfInvention |
Use of growth hormone secretagogues to block or inhibit the renin-angiotensin system |
abstract |
The invention relates to the preparation of drugs useful in the treatment of hypertension and cardiovascular disease, glucose metabolism disorders, dyslipidaemia, appetite and energy metabolism disorders and inflammatory states, through the administration of compounds which are natural and/or synthetic ghrelin analogues and growth hormone secretagogue receptor agonists and antagonists which block or inhibit the renin-angiotensin system in humans by interfering with the activity of the circulating and tissue ACE enzyme and/or with the angiotensin Il receptors and/or with the breakdown of peptide Ac-SDKP. |
priorityDate |
2006-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |